Literature DB >> 6134243

Anticonvulsant effects of some inhibitory neurotransmitter amino acids.

E Toth, A Lajtha, S Sarhan, N Seiler.   

Abstract

The anticonvulsive effects of GABA, taurine, and glycine were investigated on several chemically-induced and genetic seizure models. Intravenous injections of either GABA, taurine, or glycine provided protection against 3-mercaptopropionic acid (MPA)-induced convulsions in adult Swiss mice. GABA was partially effective against isonicotinic acid hydrazide and was without effect against bicuculline-induced convulsions. Prolonged administration of glycine prevented MPA-induced convulsions but not electrically induced seizures or seizures induced by strychnine or metrazol. Intragastric glycine protected young audiogenic seizure-susceptible DBA/2 mice against all three phases of sound-induced convulsions (wild running, clonic and tonic seizure), but GABA and taurine provided little or no protection. With increase of glycine, the cerebral levels of glutamine and serine also increased, but that of glutamic acid decreased. The endogenous glutamic and glycine levels were slightly higher in the brains of the audiogenic seizure-susceptible DBA/2 mice than in that of the resistant BALB/Cy strain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134243     DOI: 10.1007/bf00965719

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  27 in total

1.  Antagonism by taurine of cobalt induced epilepsy in cat and mouse.

Authors:  N M Van Gelder
Journal:  Brain Res       Date:  1972-11-27       Impact factor: 3.252

Review 2.  The status of glycine as a supraspinal neurotransmitter.

Authors:  C J Pycock; R W Kerwin
Journal:  Life Sci       Date:  1981-06-15       Impact factor: 5.037

Review 3.  The pharmacology of GABA-transaminase inhibitors.

Authors:  M G Palfreyman; P J Schechter; W R Buckett; G P Tell; J Koch-Weser
Journal:  Biochem Pharmacol       Date:  1981-04-15       Impact factor: 5.858

4.  The effect of the convulsant 3-mercaptopropionic acid on enzymes of the gamma-aminobutyrate system in the rat cerebral cortex.

Authors:  M Alberici de Canal; B Robiolo; M Mistrorigo de Pacheco
Journal:  J Neurochem       Date:  1973-09       Impact factor: 5.372

5.  Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors.

Authors:  P J Schechter; Y Tranier; M J Jung; P Böhlen
Journal:  Eur J Pharmacol       Date:  1977-10-15       Impact factor: 4.432

6.  Determination of the naturally occurring monoacetyl derivatives of di- and polyamines.

Authors:  N Seiler; B Knödgen
Journal:  J Chromatogr       Date:  1979-10-11

7.  Metabolic inhibitors and subcellular distribution of GABA.

Authors:  S Sarhan; N Seiler
Journal:  J Neurosci Res       Date:  1979       Impact factor: 4.164

8.  Amino acid abnormalities in epileptogenic foci.

Authors:  T L Perry; S Hansen
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

9.  Relationship between drug-induced changes in seizure thresholds and the GABA content of brain and brain nerve endings.

Authors:  W Löscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

10.  Amino acid changes in a genetic strain of epileptic beagle dogs.

Authors:  N M van Gelder; H L Edmonds; G A Hegreberg; C C Chatburn; R M Clemmons; D M Sylvester
Journal:  J Neurochem       Date:  1980-11       Impact factor: 5.372

View more
  12 in total

Review 1.  Anticonvulsant drug action and regional neurotransmitter amino acid changes.

Authors:  A G Chapman; G P Hart
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  Brain protein synthesis rates are not sensitive to elevated GABA, taurine, or glycine.

Authors:  E Toth; A Lajtha
Journal:  Neurochem Res       Date:  1984-02       Impact factor: 3.996

3.  Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.

Authors:  W Löscher; P Wlaź; C Rundfeldt; H Baran; D Hönack
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide.

Authors:  J Semba; G Curzon; P N Patsalos
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

5.  A microdialysis study of glycinamide, glycine and other amino acid neurotransmitters in rat frontal cortex and hippocampus after the administration of milacemide, a glycine pro-drug.

Authors:  M H Doheny; S Nagaki; P N Patsalos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

6.  Quinolones potentiate cefazolin-induced seizures in DBA/2 mice.

Authors:  A De Sarro; M Zappalá; A Chimirri; S Grasso; G B De Sarro
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

7.  Accumulation of labeled gamma-aminobutyric acid into rat brain and brain synaptosomes after i.p. injection.

Authors:  L Vignolo; A Cupello; P Mainardi; M V Rapallino; A Patrone; C Loeb
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

8.  Glycine potentiates the action of some anticonvulsant drugs in some seizure models.

Authors:  E Toth; A Lajtha
Journal:  Neurochem Res       Date:  1984-12       Impact factor: 3.996

9.  Evaluation of the mechanisms by which gamma-amino-butyric acid in association with phosphatidylserine exerts an antiepileptic effect in the rat.

Authors:  E Benassi; G Besio; A Cupello; P Mainardi; A Patrone; M V Rapallino; L Vignolo; C W Loeb
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

10.  Antagonism of phencyclidine-induced hyperactivity by glycine in mice.

Authors:  E Toth; A Lajtha
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.